Literature DB >> 11239674

High social anxiety and low aggression in Fawn-Hooded rats.

S Kantor1, Z E Anheuer, G Bagdy.   

Abstract

The Fawn-Hooded (FH) rat strain, with well-documented changes in their serotonergic and noradrenergic systems, is a putative genetic model for some neuropsychiatric disorders like depression, alcohol abuse, and anxiety. Because social phobia frequently occurs in combination with these disorders and there are no social anxiety-related data in FH rats in the literature, we measured the behavior of FH rats in the social interaction test. In addition, the effects of the anxiogenic Serotonin-2C (5-HT2C) receptor agonist, m-chlorophenylpiperazine (m-CPP), were studied. Male FH, Wistar (W), and Sprague-Dawley (SD) rats were used in two different test conditions of the social interaction test: the high light, unfamiliar arena, associated with high anxiety, and the low light, familiar arena, associated with low anxiety-like behavior. All social behaviors were markedly diminished in FH rats that suggested higher anxiety in these animals. Total social interaction time was reduced by 60-70% in FH rats compared either to W or SD rats under high light, unfamiliar or low light, familiar conditions, respectively. Aggressive behavior was reduced at least by 85% in FH rats. Locomotor activity and exploratory behavior were only minimally, in most comparisons, not significantly affected in FH rats. Total social interaction time, aggression, and locomotor activity were decreased, and self-grooming increased by m-CPP (0.5 mg/kg, ip) in all three strains. m-CPP decreased total social interaction time thus, caused anxiety most efficiently in FH rats (reduced by 69%, 50%, and 55% in FH, W, and SD rats, respectively), but other effects of the drug were similar in the three strains. Our studies provide evidence that the FH rat strain may be a genetic model of social phobia or other anxiety disorders with impaired social behavior.

Entities:  

Mesh:

Year:  2000        PMID: 11239674     DOI: 10.1016/s0031-9384(00)00374-7

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  11 in total

1.  Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling.

Authors:  Casey E O'Neill; Ryan J Newsom; Jacob Stafford; Talia Scott; Solana Archuleta; Sophia C Levis; Robert L Spencer; Serge Campeau; Ryan K Bachtell
Journal:  Psychoneuroendocrinology       Date:  2016-02-01       Impact factor: 4.905

Review 2.  Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives.

Authors:  Martien J Kas; Jeffrey C Glennon; Jan Buitelaar; Elodie Ey; Barbara Biemans; Jacqueline Crawley; Robert H Ring; Clara Lajonchere; Frederic Esclassan; John Talpos; Lucas P J J Noldus; J Peter H Burbach; Thomas Steckler
Journal:  Psychopharmacology (Berl)       Date:  2013-09-19       Impact factor: 4.530

3.  Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.

Authors:  Diána Kostyalik; Zita Kátai; Szilvia Vas; Dorottya Pap; Péter Petschner; Eszter Molnár; István Gyertyán; Lajos Kalmár; László Tóthfalusi; Gyorgy Bagdy
Journal:  Exp Brain Res       Date:  2014-01-07       Impact factor: 1.972

Review 4.  Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists.

Authors:  E Kirilly; L Hunyady; G Bagdy
Journal:  J Neural Transm (Vienna)       Date:  2012-09-19       Impact factor: 3.575

Review 5.  The age of anxiety: role of animal models of anxiolytic action in drug discovery.

Authors:  John F Cryan; Fabian F Sweeney
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats.

Authors:  M D S Lapiz-Bluhm; C O Bondi; J Doyen; G A Rodriguez; T Bédard-Arana; D A Morilak
Journal:  J Neuroendocrinol       Date:  2008-07-30       Impact factor: 3.627

Review 7.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

Review 8.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

9.  A selective ALDH-2 inhibitor reduces anxiety in rats.

Authors:  David H Overstreet; Darin J Knapp; George R Breese; Ivan Diamond
Journal:  Pharmacol Biochem Behav       Date:  2009-09-10       Impact factor: 3.533

10.  Behavioral Phenotyping of Juvenile Long-Evans and Sprague-Dawley Rats: Implications for Preclinical Models of Autism Spectrum Disorders.

Authors:  Katherine M Ku; Ruth K Weir; Jill L Silverman; Robert F Berman; Melissa D Bauman
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.